{"id":14672,"date":"2022-07-22T11:52:37","date_gmt":"2022-07-22T10:52:37","guid":{"rendered":"https:\/\/touchrespiratory.com\/?post_type=media_gallery&#038;p=14672"},"modified":"2022-07-22T11:52:37","modified_gmt":"2022-07-22T10:52:37","slug":"mario-cazzola-chest-2022-bronchodilator-interactions-with-therapeutics-for-copd-comorbidities","status":"publish","type":"media_gallery","link":"https:\/\/touchrespiratory.com\/copd\/conference-hub\/mario-cazzola-chest-2022-bronchodilator-interactions-with-therapeutics-for-copd-comorbidities\/","title":{"rendered":"Mario Cazzola, CHEST 2022: Bronchodilator Interactions with Therapeutics for COPD Comorbidities"},"content":{"rendered":"<p>COPD is associated with multiple comorbidities such as cardiovascular diseases, depression, and diabetes mellitus. Bronchodilators are often used in the management of COPD, but can also have an effect on comorbidities. We caught up with editorial board member <strong>Professor Mario Cazzola<\/strong> (University of Rome \u2018Tor Vergata\u2019, Rome, Italy) to discuss bronchodilator selection in patients with COPD and the importance of minimising the risk of drug interactions.<\/p>\n<p>\u2018<b>What\u2019s New in COPD Pharmacology<\/b><b>\u2019\u00a0<\/b>was presented at\u00a0<a href=\"https:\/\/chestcongress2022.com\/\" target=\"_blank\" rel=\"noopener\">CHEST Congress 2022<\/a>, 27-29 June 2022.<\/p>\n<p><strong>Questions<\/strong><\/p>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">What are the potential interactions between bronchodilators and drugs used to treat comorbidities? (0:42)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">What questions should be asked when selecting bronchodilators for COPD? (5:19)<\/span><\/li>\n<\/ol>\n<p><b>Disclosures:<\/b>\u00a0Mario Cazzola\u00a0has nothing to disclose in relation to this video interview.<\/p>\n<p><b>Support:<\/b>\u00a0Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.<\/p>\n<p><b><i>Filmed in coverage of the CHEST meeting 2022.<\/i><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COPD is associated with multiple comorbidities such as cardiovascular diseases, depression, and diabetes mellitus. Bronchodilators are often used in the management of COPD, but can also have an effect on comorbidities. We caught up with editorial board member Professor Mario Cazzola (University of Rome \u2018Tor Vergata\u2019, Rome, Italy) to discuss bronchodilator selection in patients with [&hellip;]<\/p>\n","protected":false},"featured_media":14670,"template":"","class_list":["post-14672","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-copd","video_categories-chest-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14672"}],"collection":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":1,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14672\/revisions"}],"predecessor-version":[{"id":14673,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14672\/revisions\/14673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media\/14670"}],"wp:attachment":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media?parent=14672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}